These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9002956)

  • 1. Antithrombotic efficacy in the guinea pig of a derivative of human protein C with enhanced activation by thrombin.
    Kurz KD; Smith T; Wilson A; Gerlitz B; Richardson MA; Grinnell BW
    Blood; 1997 Jan; 89(2):534-40. PubMed ID: 9002956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.
    Chen C; Yang L; Villoutreix BO; Wang X; Ding Q; Rezaie AR
    Thromb Haemost; 2017 Jun; 117(7):1358-1369. PubMed ID: 28405673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates.
    Gruber A; Marzec UM; Bush L; Di Cera E; Fernández JA; Berny MA; Tucker EI; McCarty OJ; Griffin JH; Hanson SR
    Blood; 2007 May; 109(9):3733-40. PubMed ID: 17227834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of activated human protein C on experimental venous thrombosis induced by stasis with operative invasion in mice.
    Aoki Y; Fukumoto Y; Inoue K; Katsuura Y; Komoriya K; Miyamoto S
    Arzneimittelforschung; 2000 Aug; 50(8):695-9. PubMed ID: 10994152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Gly197 in the structure and function of protein C.
    Lu Y; Biswas I; Villoutreix BO; Rezaie AR
    Biochim Biophys Acta Gen Subj; 2021 Jun; 1865(6):129892. PubMed ID: 33722640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of activated protein C in guinea pigs.
    Berger H; Kirstein CG; Orthner CL
    Blood; 1991 May; 77(10):2174-84. PubMed ID: 2029578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates.
    Gruber A; Fernández JA; Bush L; Marzec U; Griffin JH; Hanson SR; DI Cera E
    J Thromb Haemost; 2006 Feb; 4(2):392-7. PubMed ID: 16420571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin spatial distribution determines protein C activation during hemostasis and thrombosis.
    Marar TT; Matzko CN; Wu J; Esmon CT; Sinno T; Brass LF; Stalker TJ; Tomaiuolo M
    Blood; 2022 Mar; 139(12):1892-1902. PubMed ID: 34890454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates.
    Gruber A; Harker LA; Hanson SR; Kelly AB; Griffin JH
    Circulation; 1991 Dec; 84(6):2454-62. PubMed ID: 1835678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
    Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A
    J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates.
    Tanaka KA; Fernández JA; Marzec UM; Kelly AB; Mohri M; Griffin JH; Hanson SR; Gruber A
    Br J Haematol; 2006 Jan; 132(2):197-203. PubMed ID: 16398653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic effects of activated protein C and protein S in a rabbit model of microarterial thrombosis.
    Arnljots B; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):937-41. PubMed ID: 7600126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model.
    Heeb MJ; Marzec U; Gruber A; Hanson SR
    Thromb Haemost; 2012 Apr; 107(4):690-8. PubMed ID: 22370911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of protease domain residues Lys37-39 in human protein C inhibits activation by the thrombomodulin-thrombin complex without affecting activation by free thrombin.
    Gerlitz B; Grinnell BW
    J Biol Chem; 1996 Sep; 271(37):22285-8. PubMed ID: 8798383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited abnormalities in the protein C activation pathway.
    España F; Medina P; Navarro S; Estellés A; Aznar J
    Pathophysiol Haemost Thromb; 2002; 32(5-6):241-4. PubMed ID: 13679649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M-AAA-thrombin: potent anticoagulant and antiplatelet thrombin derivative with differential affinity for factor VIII and PAR1.
    Hosokawa K; Matsuda H; Ohnishi T; Gonda M; Koide T
    Thromb Res; 2010 Nov; 126(5):447-53. PubMed ID: 20870278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
    Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
    Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ser252Asn Mutation Introduces a New N-Linked Glycosylation Site and Causes Type IIb Protein C Deficiency.
    Zhou S; Wu X; Song Y; Li L; Shi C; Lai Z; Ding Q; Wu W; Dai J; Wang X; Lu Y
    Thromb Haemost; 2024 May; 124(5):459-470. PubMed ID: 38011863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.